1. Home
  2. BOW vs LXEO Comparison

BOW vs LXEO Comparison

Compare BOW & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

HOLD

Current Price

$24.97

Market Cap

913.3M

Sector

Finance

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$7.63

Market Cap

731.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOW
LXEO
Founded
2020
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
913.3M
731.3M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
BOW
LXEO
Price
$24.97
$7.63
Analyst Decision
Buy
Strong Buy
Analyst Count
6
10
Target Price
$35.00
$18.60
AVG Volume (30 Days)
187.8K
1.3M
Earning Date
02-24-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
44.06
N/A
EPS
1.55
N/A
Revenue
$519,241,000.00
N/A
Revenue This Year
$16.05
N/A
Revenue Next Year
$25.43
N/A
P/E Ratio
$15.80
N/A
Revenue Growth
33.44
N/A
52 Week Low
$23.50
$1.45
52 Week High
$42.29
$10.99

Technical Indicators

Market Signals
Indicator
BOW
LXEO
Relative Strength Index (RSI) 45.33 41.22
Support Level $24.12 $7.12
Resistance Level $25.80 $7.75
Average True Range (ATR) 0.93 0.44
MACD 0.04 0.00
Stochastic Oscillator 61.20 51.83

Price Performance

Historical Comparison
BOW
LXEO

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: